Efficacy, Dosage Concerns Unresolved On Sublingual Immunotherapy
Although sublingual immunotherapy (SLIT) is used in Europe and other countries, experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle say questions remain unanswered regarding its effectiveness, appropriate use, dosage, and safety of administration.
More: continued here
Filed under: Allergies on November 7th, 2008